Clinical Trials in Bay City, United States
Locations / Bay City, United States
Delta Trials lists 15 clinical trials conducted in Bay City, United States, making it a notable site of clinical research activity. These trials addressing 59 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Bay City research landscape.
15
Total Trials
59
Conditions
1
Terminated since 2020
Browse by condition (59 total)
- Invasive breast carcinoma 2 trialsAll Invasive breast carcinoma trials
- All Clinical stage ii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 trials
- All Stage ii bladder urothelial carcinoma ajcc v6 and v7 trials
- Squamous cell carcinoma 1 trialAll Squamous cell carcinoma trials
- Hormone receptor positive 1 trialAll Hormone receptor positive trials
- Malignant solid neoplasm 1 trialAll Malignant solid neoplasm trials
- Anal basaloid carcinoma 1 trialAll Anal basaloid carcinoma trials
- All Clinical stage iii hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 trials
- All Stage ii breast cancer ajcc v6 and v7 trials
- All Clinical stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 trials
- All Muscle invasive bladder urothelial carcinoma trials
- All Synchronous bilateral breast carcinoma trials
- All Stage iv colorectal cancer ajcc v7 trials
- Covid-19 infection 1 trialAll Covid-19 infection trials
- Stage iib colon cancer ajcc v7 1 trialAll Stage iib colon cancer ajcc v7 trials
- Stage iii anal cancer ajcc v8 1 trialAll Stage iii anal cancer ajcc v8 trials
- All Pathologic stage i hpv-mediated (p16-positive) oropharyngeal carcinoma ajcc v8 trials
- Stage iiib breast cancer ajcc v7 1 trialAll Stage iiib breast cancer ajcc v7 trials
- All Stage iii bladder urothelial carcinoma ajcc v6 and v7 trials
- All Stage iib breast cancer ajcc v6 and v7 trials